These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31803613)
1. Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy. Veselska R; Jezova M; Kyr M; Mazanek P; Chlapek P; Dobrotkova V; Sterba J Front Oncol; 2019; 9():1221. PubMed ID: 31803613 [TBL] [Abstract][Full Text] [Related]
2. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers. Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873 [TBL] [Abstract][Full Text] [Related]
3. Histone demethylase KDM6B has an anti-tumorigenic function in neuroblastoma by promoting differentiation. Yang L; Zha Y; Ding J; Ye B; Liu M; Yan C; Dong Z; Cui H; Ding HF Oncogenesis; 2019 Jan; 8(1):3. PubMed ID: 30631055 [TBL] [Abstract][Full Text] [Related]
4. PBX1 is a valuable prognostic biomarker for patients with breast cancer. Ao X; Ding W; Ge H; Zhang Y; Ding D; Liu Y Exp Ther Med; 2020 Jul; 20(1):385-394. PubMed ID: 32565927 [TBL] [Abstract][Full Text] [Related]
5. Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. Xuan F; Huang M; Liu W; Ding H; Yang L; Cui H Neuro Oncol; 2016 Jun; 18(6):819-29. PubMed ID: 26582930 [TBL] [Abstract][Full Text] [Related]
6. Clinical Prognostic Significance of HOXC9 Expression in Patients with Colorectal Cancer. Hu M; Ou-Yang W; Jing D; Chen R Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414766 [TBL] [Abstract][Full Text] [Related]
7. The prognostic role of E2A-PBX1 expression detected by real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) in B cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Hong Y; Zhao X; Qin Y; Zhou S; Chang Y; Wang Y; Zhang X; Xu L; Huang X Ann Hematol; 2018 Sep; 97(9):1547-1554. PubMed ID: 29705861 [TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols. Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874 [TBL] [Abstract][Full Text] [Related]
9. Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting. Karvonen H; Perttilä R; Niininen W; Hautanen V; Barker H; Murumägi A; Heckman CA; Ungureanu D Oncogene; 2019 Apr; 38(17):3288-3300. PubMed ID: 30631148 [TBL] [Abstract][Full Text] [Related]
10. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma. Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006 [TBL] [Abstract][Full Text] [Related]
11. Identification of DDX39A as a Potential Biomarker for Unfavorable Neuroblastoma Using a Proteomic Approach. Otake K; Uchida K; Ide S; Kobayashi Y; Kobayashi I; Kusunoki M Pediatr Blood Cancer; 2016 Feb; 63(2):221-7. PubMed ID: 26469522 [TBL] [Abstract][Full Text] [Related]
12. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106 [TBL] [Abstract][Full Text] [Related]
13. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472 [TBL] [Abstract][Full Text] [Related]
14. Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system. Suc A; Lumbroso J; Rubie H; Hattchouel JM; Boneu A; Rodary C; Robert A; Hartmann O Cancer; 1996 Feb; 77(4):805-11. PubMed ID: 8616776 [TBL] [Abstract][Full Text] [Related]
15. High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN status. Westermann F; Henrich KO; Wei JS; Lutz W; Fischer M; König R; Wiedemeyer R; Ehemann V; Brors B; Ernestus K; Leuschner I; Benner A; Khan J; Schwab M Clin Cancer Res; 2007 Aug; 13(16):4695-703. PubMed ID: 17652624 [TBL] [Abstract][Full Text] [Related]
16. Synergy between loss of NF1 and overexpression of MYCN in neuroblastoma is mediated by the GAP-related domain. He S; Mansour MR; Zimmerman MW; Ki DH; Layden HM; Akahane K; Gjini E; de Groh ED; Perez-Atayde AR; Zhu S; Epstein JA; Look AT Elife; 2016 Apr; 5():. PubMed ID: 27130733 [TBL] [Abstract][Full Text] [Related]
17. The leukemogenic transcription factor E2a-Pbx1 induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Rutherford MN; Bayly GR; Matthews BP; Okuda T; Dinjens WM; Kondoh H; LeBrun DP Leukemia; 2001 Mar; 15(3):362-70. PubMed ID: 11237058 [TBL] [Abstract][Full Text] [Related]
18. Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1. Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741 [TBL] [Abstract][Full Text] [Related]
19. A hydrophobic residue in the TALE homeodomain of PBX1 promotes epithelial-to-mesenchymal transition of gastric carcinoma. He C; Wang Z; Zhang L; Yang L; Li J; Chen X; Zhang J; Chang Q; Yu Y; Liu B; Zhu Z Oncotarget; 2017 Jul; 8(29):46818-46833. PubMed ID: 28514754 [TBL] [Abstract][Full Text] [Related]
20. [Correlation of E2a-pbx1 expression level with clinical characteristics and early response to treatment in children with acute lymphoblastic leukemia]. Gao C; Li ZG; Zhao W; Wu MY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):569-73. PubMed ID: 18549631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]